FIELD: veterinary medicine.
SUBSTANCE: present invention relates to a method for the preventive treatment of an animal against infection with porcine circovirus type 2 (hereinafter – PCV2), Mycoplasma hyopneumoniae infection and infection with virus of porcine reproductive and respiratory syndrome (hereinafter – PRRS) by associated unmixed administration of the first vaccine containing a non-replicating immunogen of porcine circovirus type 2 (PCV2) and a non–replicating immunogen of Mycoplasma hyopneumoniae, and the second vaccine containing a live attenuated virus of porcine reproductive and respiratory syndrome (PRRS) to an animal.
EFFECT: this method allows one to enhance the protection against PCV2 when PRRS is administered by an associated unmixed method.
9 cl, 2 dwg, 2 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PORCINE CIRCOVIRUS TYPE 2 VACCINE | 2014 |
|
RU2712155C2 |
INTRADERMAL VACCINE AGAINST PCV2 AND PRRS VIRUS INFECTION | 2017 |
|
RU2746127C2 |
COMBINED PORCINE VACCINE | 2017 |
|
RU2761453C2 |
VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2 | 2014 |
|
RU2672251C1 |
COMBINED VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE | 2013 |
|
RU2615443C2 |
VACCINE FOR PROTECTION AGAINST LAWSONIAINTRACELLULARIS, MYCOPLASMA HYOPNEUMONIAE AND PORCINE CIRCOVIRUS | 2009 |
|
RU2496520C2 |
COMBINATION VACCINE PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS (PCV/MYCOPLASMA HYOPNEUMONIAE/PRRS COMBINATION VACCINE) | 2013 |
|
RU2644256C2 |
MYCOPLASMA AND PRRSV VACCINE | 2007 |
|
RU2408386C2 |
MYCOPLASMA HYOPNEUMONIAE VACCINE | 2013 |
|
RU2644254C2 |
VACCINE AGAINST LAWSONIA INTRACELLULARIS | 2009 |
|
RU2523561C2 |
Authors
Dates
2021-10-05—Published
2018-04-12—Filed